Parties
Identify full legal names and formation jurisdictions for the acquiring entity and the target to avoid ambiguity in enforceability and filing.
A well-prepared Exhibit 22 creates a definitive, signed record of merger terms, reduces ambiguity at closing, supports regulatory compliance, and helps streamline shareholder and corporate approvals.
Typical participants in preparing or signing Exhibit 22 documents include corporate counsel, company officers, board representatives, and transaction support staff.
Final circulation usually includes retained copies for corporate records, counsel, and any regulatory or filing parties.
An officer with delegated corporate authority (CEO, President, CFO, or other designee) typically signs on behalf of a party to bind the corporation and certify that corporate approvals were obtained and that the exhibit reflects authorized transaction terms.
A director or board committee chair may sign or countersign to confirm that required board resolutions and shareholder approvals have been obtained under the corporation's governing documents and applicable state corporate law.
Identify full legal names and formation jurisdictions for the acquiring entity and the target to avoid ambiguity in enforceability and filing.
Specify cash amounts, stock exchange ratios, or other consideration types with precise calculations and any rounding rules.
State the effective date or the mechanism for determining it, as it affects tax treatment, liabilities, and statutory filing deadlines.
List required approvals, regulatory clearances, and third‑party consents needed before the merger can close.
Summarize key representations and any survival periods, or reference the primary agreement for full language.
Describe steps at closing, deliverables, escrow instructions, and who records or files the executed exhibit with corporate books.
| Field | Configuration |
|---|---|
| Signer Order | Set role-based sequential signing to ensure board and officer signatures occur in correct order. |
| Authentication | Require email plus SMS or KBA for higher-value transactions to strengthen signer attribution. |
| Template Use | Create a reusable Exhibit 22 template to reduce manual errors across transactions. |
| Retention Policy | Enable audit trail retention aligned to corporate recordkeeping and regulatory timelines. |
Select distribution methods and integrations that align with corporate recordkeeping and security controls.
Ensure chosen platform supports audit trails, secure storage, and exports for legal and regulatory access.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day trial | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | Yes |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
Optica used Exhibit 22 to record a stock-for-stock merger
A real estate holding company attached Exhibit 22 to a corporate reorganization filing
Date when parties execute the Exhibit 22 and primary agreement.
Date specified in the exhibit that controls tax and liability timing.
State corporate filings should follow jurisdiction requirements promptly after closing.
Deliver notices according to charter and state law prior to effective date.
Preserve executed copies per retention timeline for audit readiness.
Draft the Exhibit 22 and cross-check against the primary merger agreement.
Complete board and shareholder approvals and regulatory clearances as required.
Collect authorized signatures and notarizations or RON sessions as applicable.
File required corporate forms and retain copies with corporate records.
| Criteria | Exhibit 22 | Full Agreement |
|---|---|---|
| Purpose | concise record | comprehensive terms |
| Filing required | often attached | may be main document |
| Notarization | rarely required | rarely required |
| Typical signers | authorized officers | parties and counsel |